Sustained HPV-16 and 18 Antibody Levels Through 5.5 Years in Women Vaccinated with the HPV-16/18 L1 VLP AS04 Candidate Vaccine by Diane M. Harper given during the 15th International Meeting of the European Society of Gynaecological Oncology (ESGO) powered by - MULTIWEBCAST

15th International Meeting of the European Society of Gynaecological Oncology (ESGO)

LIST OF PRESENTATIONS

OTHER WEBCASTS

Webcasted Presentation

BROWSE:

Diane M. Harper

United States of America

Sustained HPV-16 and 18 Antibody Levels Through 5.5 Years in Women Vaccinated with the HPV-16/18 L1 VLP AS04 Candidate Vaccine

English

2007-10-31

PRESENTATION

17 slide(s)

Extra Features Available

SLIDE LIBRARY

Disclosure

- Research support from Sanofi Pasteur/Aventis and GSK
- Consultant Sanofi Pasteur/Aventis and GSK, specifically for the HPV Vaccines Trials

Disclaimer ^{AMENDED ON January 29, 2009} | Close This Window | Technical Support

USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.

Search’n Build™ Search presentations by keyword and instantly build your own highlight of the conference!

Search’n Build™
Search presentations by keyword and instantly build your own highlight of the conference!